Cerapedics receives $20M loan from Oxford Finance

Cerapedics receives $20M loan from Oxford Finance

WESTMINSTER -- Virginia-based Oxford Finance LLC announced closing a$20 millionsenior secured term loan with Cerapedics Inc. , a privately-held orthobiologics company engaged in the development... Read More

Thursday April 20, 2017 0 comments Tags: Westminster, Cerapedics, Oxford Financing, i-FACTOR, Christopher A. Herr, Glen Kashuba

Cerapedics announces closing of $11M Series D round to expand products

Cerapedics announces closing of $11M Series D round to expand products

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the completion of an $11 million Series D financing. The company said the funds will be used to expand... Read More

Friday September 30, 2016 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, i-FACTOR

Cerapedics gets FDA approval for i-FACTOR bone graft to repair cervical disc degeneration

Cerapedics gets FDA approval for i-FACTOR bone graft to repair cervical disc degeneration

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the FDA has approved the companys Premarket Approval application for i-FACTOR Peptide Enhanced Bone Graft for use in... Read More

Wednesday November 4, 2015 0 comments Tags: Westminster, Cerapedics, i-FACTOR, bone grafts, Jeffrey G. Marx, Glen Kashuba, FDA

Cerapedics closes on $4M loan from GE Capital

Cerapedics closes on $4M loan from GE Capital

WESTMINSTER Cerapedics , a privately-held orthobiologics company, today announced closing of a $4 million term loan from GE Capital Healthcare Financial Services, bringing the total facility to... Read More

By: InnovatioNews Tuesday April 7, 2015 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, i-FACTOR, GE Capital

Cerapedics: First i-FACTOR bone graft clinical study shows significant favorable outcomes

Cerapedics: First i-FACTOR bone graft clinical study shows significant favorable outcomes

WESTMINSTER - Cerapedics announced results from the first prospective clinical study evaluating the safety and efficacy of its i-FACTOR bone graft in anterior lumbar interbody fusion (ALIF)... Read More

By: InnovatioNews Tuesday October 21, 2014 0 comments Tags: bone grafts, Cerapedics, Dr.Ralph Mobbs, i-FACTOR, Westminster

Cerapedics closes on $9M loan from GE Capital

Cerapedics closes on $9M loan from GE Capital

WESTMINSTER - Cerapedics , an orthobiologics company focused on developing and commercializing its proprietary synthetic peptide technology program, announced it has closed on a $9 million venture... Read More

By: InnovatioNews Tuesday April 15, 2014 0 comments Tags: Cerapedics, GE Capital, Glen Kashuba, i-FACTOR, Jeffrey G. Marx, Westminster

Cerapedics treats 10,000th patient with i-FACTOR bone graft

Cerapedics treats 10,000th patient with i-FACTOR bone graft

WESTMINSTER - Cerapedics Inc ., a medical device company pioneering the use of peptide-enhanced bone grafting materials in spine, trauma and orthopedic surgery, announced it has treated more... Read More

By: Steve Monday March 4, 2013 0 comments Tags: Cerapedics, i-FACTOR, Steve McAdoo, Westminster

Cerapedics secures $19M in equity financing to advance bone graft R&D

Cerapedics secures $19M in equity financing to advance bone graft R&D

WESTMINSTER - Cerapedics Inc. today announced it has completed a Series C round of private equity financing totaling $19 million. The new round was led by new investors Medimmune Ventures... Read More

By: Steve Wednesday December 12, 2012 0 comments Tags: Cerapedics, CVF LLC, i-FACTOR, Medimmune Ventures, NGN Capital, OrbiMed Advisors, osteobiologics, Paul Mraz, Sam Wu, Westminster